Dr. Sciurba is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 5th Ave
# 4
Pittsburgh, PA 15213Phone+1 412-648-6161
Summary
- Dr. Frank Sciurba is a pulmonologist in Pittsburgh, PA and is affiliated with UPMC Presbyterian. He received his medical degree from University of Chicago Pritzker School of Medicine and has been in practice 35 years. He specializes in Personalized approaches to COPD and Emphysema, and pulmonary rehabilitation and is experienced in pulmonary function testing, cardiopulmonary exercise testing, device and biologic intervention in copd, and clinical trials and translational research in copd.
Education & Training
- UPMC Medical EducationFellowship, Pulmonary Disease and Critical Care Medicine, 1986 - 1988
- UPMC Medical EducationResidency, Internal Medicine, 1982 - 1984
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1982
Certifications & Licensure
- PA State Medical License 1984 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
- Endobronchial Valve for Emphysema Palliation Trial (VENT) Start of enrollment: 2004 Jan 01
- Emphysema Research Registry and Biosample Repository Start of enrollment: 2000 Aug 01
- Benefits of Lightweight Ambulatory Oxygen Systems for Individuals With Chronic Obstructive Pulmonary Disease Start of enrollment: 2005 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- STAR Has Better Discrimination for Mortality than ERS/ATS Chronic Obstructive Pulmonary Disease Severity Classification.Surya P Bhatt, Arie Nakhmani, Spyridon Fortis, Matthew J Strand, Edwin K Silverman
American Journal of Respiratory and Critical Care Medicine. 2024-12-01 - A Ramped Treadmlll Protocol Exercise Test Identifies Higher Ambulatory Oxygen Needs in IPF and COPD.Kristopher P Clark, Seyed Mehdi Nouraie, Kathleen O Lindell, Kevin F Gibson, Frank C Sciurba
Annals of the American Thoracic Society. 2024-11-20 - Interpretable machine learning uncovers epithelial transcriptional rewiring and a role for Gelsolin in COPD.Justin Sui, Hanxi Xiao, Ugonna Mbaekwe, Nai-Chun Ting, Kaley Murday
JCI Insight. 2024-11-08
Press Mentions
- PRE-PROOF Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation PRE-PROOFDecember 22nd, 2022
- COPD Community: Where to Find SupportJanuary 28th, 2021
- Managing Chronic Lung Diseases During the PandemicApril 29th, 2020
- Join now to see all
Grant Support
- Peripheral Markers Of Phenotypic Heterogeneity In COPDNational Heart, Lung, And Blood Institute2007–2012
- Molecular And Cellular Determinants Of Disease Heterogeneity In COPDNational Heart, Lung, And Blood Institute2007–2012
- ClinicalNational Heart, Lung, And Blood Institute2007–2012
- AdministrativeNational Heart, Lung, And Blood Institute2007–2012
- Lung Genomics Research ConsortiumNational Heart, Lung, And Blood Institute2010
- Lung Genomics Research ConsortiumNational Heart, Lung, And Blood Institute2009–2010
- UnknownNational Heart, Lung, And Blood Institute2007
- COPD Clinical Research NetworkNational Heart, Lung, And Blood Institute2004–2007
- Lung Tissue Research Consortium (Ltrc): Clinical CenterNational Center For Research Resources2005
- Feasibility Of Retinoid Therapy For Emphysema (FORTE)National Center For Research Resources2004
- Feasibility Studies On Retinoid Treatment In EmphysemaDivision Of Lung Diseases1999–2000
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: